ACAD vs AAPL · P/E 15, rev $576.0M vs P/E 39, rev $416.16B
ACADIA Pharmaceuticals Inc (ACAD) versus Apple Inc (AAPL) — a side-by-side from cached financials, not a winner call.
ACADIA Pharmaceuticals Inc (ACAD) is a biotechnology company listed on US.
Apple Inc (AAPL) is a consumer electronics company listed on US. It is led by Timothy D. Cook.
Latest reported ACAD revenue for 2026-06-30 was $576.0M. Net income was $35.1M. ACAD currently screens at market cap $3.51B and trailing P/E 15.3.
Latest reported AAPL revenue for 2025-09-27 was $416.16B. Net income was $112.01B. Revenue was up 6.4% from 2024-09-28 to 2025-09-27. AAPL currently screens at market cap $3.83T and trailing P/E 39.2.
ACAD currently screens at market cap $3.51B and trailing P/E 15.3. AAPL currently screens at market cap $3.83T and trailing P/E 39.2.
Not investment advice. Open the ACAD and AAPL stock pages for the full models.
Not investment advice.